These authors further characterized RUNX1 expression in critical cell types involved in a laser-induced murine model of Choroidal Neovascularization (CNV) and provided data supporting RUNX1 inhibition as a new potential therapy for neovascular age-related macular degeneration [144]. Here, RUNX1 is linked to age-related macular degeneration.